期刊
CURRENT OPINION IN OPHTHALMOLOGY
卷 24, 期 5, 页码 453-462出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ICU.0b013e3283641ede
关键词
biologic agents; immunosuppressive therapy; juvenile idiopathic arthritis; pediatric uveitis; uveitis
资金
- Intramural NIH HHS [Z99 EY999999] Funding Source: Medline
Purpose of reviewPediatric uveitis is relatively uncommon, accounting for only 5-10% of all patients with uveitis. However, owing to high prevalence of complications and devastating outcomes, its lifetime burden can be significant.Recent findingsImmunomodulatory therapy has been associated with better outcomes in noninfectious pediatric uveitis. However, effective treatments are limited by medication-related complications, including multiorgan toxicities and systemic side effects.SummaryWe review the current therapies available to treat pediatric uveitis, discuss novel and future therapies, and provide clinical recommendations utilizing these new agents. The consideration for treatment regimens in noninfectious pediatric uveitis is multifactorial. Understanding past, present, and future technology will aid in treatment of a complex and refractory disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据